Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy
- 1 March 2005
- journal article
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 15 (3), 212-217
- https://doi.org/10.1038/sj.cr.7290289
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With GefitinibJournal of Clinical Oncology, 2005
- EGFR Gene Mutations: A Call for Global x Global Views of CancerJNCI Journal of the National Cancer Institute, 2005
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJNCI Journal of the National Cancer Institute, 2005
- Chasing Mutations in the Epidermal Growth Factor in Lung CancerNew England Journal of Medicine, 2005
- High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in TaiwanClinical Cancer Research, 2004
- Mutations of the Epidermal Growth Factor Receptor Gene in Lung CancerCancer Research, 2004
- Targeted Therapies for Cancer 2004American Journal of Clinical Pathology, 2004
- A Bull's Eye for Targeted Lung Cancer TherapyScience, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004